Effector and regulatory B cells in immune-mediated kidney disease

K Oleinika, C Mauri, AD Salama - Nature Reviews Nephrology, 2019 - nature.com
B cells have a central role in many autoimmune diseases, including in those with renal
involvement, as well as in the immunological response to kidney transplantation. The …

Autoimmune pathology in myasthenia gravis disease subtypes is governed by divergent mechanisms of immunopathology

ML Fichtner, R Jiang, A Bourke, RJ Nowak… - Frontiers in …, 2020 - frontiersin.org
Myasthenia gravis (MG) is a prototypical autoantibody mediated disease. The
autoantibodies in MG target structures within the neuromuscular junction (NMJ), thus …

B cell checkpoints in autoimmune rheumatic diseases

SJS Rubin, MS Bloom, WH Robinson - Nature Reviews Rheumatology, 2019 - nature.com
B cells have important functions in the pathogenesis of autoimmune diseases, including
autoimmune rheumatic diseases. In addition to producing autoantibodies, B cells contribute …

B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets

TG Forsthuber, DM Cimbora… - Therapeutic …, 2018 - journals.sagepub.com
Increasing recognition of the role of B cells in the adaptive immune response makes B cells
an important therapeutic target in autoimmunity. Numerous current and developmental …

Plasma cells are the most abundant gluten peptide MHC-expressing cells in inflamed intestinal tissues from patients with celiac disease

LS Høydahl, L Richter, R Frick, O Snir, KS Gunnarsen… - Gastroenterology, 2019 - Elsevier
Background & Aims Development of celiac disease is believed to involve the
transglutaminase-dependent response of CD4+ T cells toward deamidated gluten peptides …

[HTML][HTML] A nondepleting anti-CD19 antibody impairs B cell function and inhibits autoimmune diseases

JS Boyles, D Sadowski, S Potter, A Vukojicic, J Parker… - JCI insight, 2023 - ncbi.nlm.nih.gov
B cells contribute to multiple aspects of autoimmune disorders, and B cell–targeting
therapies, including B cell depletion, have been proven to be efficacious in treatment of …

Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients

KM Telesford, L Amezcua, L Tardo, L Horton… - Frontiers in …, 2023 - frontiersin.org
People identified with Black/African American or Hispanic/Latinx ethnicity are more likely to
exhibit a more severe multiple sclerosis disease course relative to those who identify as …

Inebilizumab, a B cell-depleting anti-CD19 antibody for the treatment of autoimmune neurological diseases: insights from preclinical studies

D Chen, S Gallagher, NL Monson, R Herbst… - Journal of clinical …, 2016 - mdpi.com
Exaggerated or inappropriate responses by B cells are an important feature in many types of
autoimmune neurological diseases. The recent success of B-cell depletion in the treatment …

Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis

NL Ciano-Petersen, S Muñiz-Castrillo… - Brain …, 2022 - academic.oup.com
Autoimmune encephalitides constitute a diverse group of immune-mediated central nervous
system disorders mainly characterized by the presence of antibodies targeting neuronal or …

B cell-activating factor and its targeted therapy in autoimmune diseases

Y Zhang, J Tian, F Xiao, L Zheng, X Zhu, L Wu… - Cytokine & growth factor …, 2022 - Elsevier
B cells play a pivotal role in the pathogenesis of autoimmune disease (AD) by the production
of autoantibodies, secretion of cytokines and presentation of autoantigens. As a pro-survival …